Ulcerative colitis Trials in Vác, Hungary
Conditions / Ulcerative colitis / Vác, Hungary
Research into Ulcerative colitis spans multiple therapeutic approaches and trial phases.
25 total trials for this combination
Showing top 10 of 25 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01458574 | A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT01465763 | A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT03283085 | A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) | COMPLETED | PHASE3 |
| NCT03524092 | A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT03519945 | A Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 3) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03290781 | An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT03518086 | An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) | COMPLETED | PHASE3 |
| NCT07186101 | LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis: | RECRUITING | — |
| NCT03259308 | Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis | TERMINATED | PHASE3 |
| NCT01470612 | Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis | COMPLETED | PHASE3 |